Well being Canada has accredited the primary generic semaglutide injection for weight reduction.
The product from the Canadian firm Apotex is called Svemia and is a generic model of the brand-name drug Wegovy from Denmark’s Novo Nordisk.
Get weekly well being information
Obtain the newest medical information and well being data delivered to you each Sunday.
Well being Canada says Svemia is for the once-weekly therapy of individuals 12 and over, as a complement to a reduced-calorie weight loss plan and elevated bodily exercise for power weight administration.
It’s the third generic semaglutide product accredited by the division, although the primary two have been licensed for the therapy of Kind 2 diabetes in adults.
Generic variations of Novo Nordisk’s Ozempic by India-based Dr. Reddy’s Laboratories and Apotex have been accredited earlier this 12 months.
Well being Canada says it’s reviewing six different submissions for generic semaglutide from totally different corporations and expects to make extra selections within the coming weeks and months.
© 2026 The Canadian Press
